GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 14th, there was short interest totaling 509 shares, a decrease of 90.1% from the July 30th total of 5,166 shares. Based on an average trading volume of 10,463 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.
GMO U.S. Value ETF Stock Down 0.5%
Shares of GMOV traded down $0.16 during midday trading on Thursday, hitting $32.66. The company had a trading volume of 2,668 shares, compared to its average volume of 15,938. The company’s 50 day moving average price is $31.24 and its 200 day moving average price is $29.91. The stock has a market cap of $104.51 million, a price-to-earnings ratio of 12.08 and a beta of 0.62. GMO U.S. Value ETF has a 52 week low of $25.66 and a 52 week high of $32.88.
Institutional Investors Weigh In On GMO U.S. Value ETF
A number of institutional investors have recently made changes to their positions in the company. Fifth Third Bancorp acquired a new stake in shares of GMO U.S. Value ETF during the 1st quarter valued at approximately $84,000. Pathway Financial Advisors LLC acquired a new stake in shares of GMO U.S. Value ETF during the second quarter worth $246,000. Kestra Private Wealth Services LLC bought a new position in shares of GMO U.S. Value ETF in the 1st quarter worth about $333,000. Aspen Investment Management Inc bought a new position in shares of GMO U.S. Value ETF in the 4th quarter worth about $333,000. Finally, RPS Advisory Solutions LLC acquired a new position in shares of GMO U.S. Value ETF in the 4th quarter valued at about $484,000.
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
See Also
- Five stocks we like better than GMO U.S. Value ETF
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
